Showing results (441-450 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 24, 2023
Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosisDhruv Jain, Charles N Bernstein, Lesley A Graff, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 30, 2026
Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitisAisha Elfasi, Samir Alkabie, Elsa Rodriguez, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 9, 2026
Ocular-motor conduction dynamics and variability in multiple sclerosis-related internuclear ophthalmoparesis: A randomized dalfampridine trialAlessandro Serra, Clara Chisari, Jonathan B Jacobs, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 25, 2026
Circulating microRNA expression profiles as biomarkers of disease activity in multiple sclerosisIfat Vigiser, Yoav Zeevi, Yoav Piura, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 23, 2026
Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samplesTyler L Borko, Alanna Ritchie, Sean Selva, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2026
Sex-dependent bioactive lipid mediator profiles in multiple sclerosisWing Hee Fung, Serhii Chornyi, Menno M Schoonheim, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 23, 2026
Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registryKaarina Kowalec, Douglas Menendez, Gary Cutter, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 29, 2025
Diffusion tensor imaging in the SPRINT-MS clinical trial: Advancing trial methodologyKen Sakaie, Mengke Du, Nancy Obuchowski, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2018
A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosisAndrew Eisen, Benjamin M Greenberg, James D Bowen, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2018
Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosisThomas J Covey, Janet L Shucard, Ralph Hb Benedict, et al.Pageof 61